Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung CancerNitin Roper, Udayan Guha, Christopher Trindade et al.|Cell Reports Medicine|2020Cited by 186
Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid TumorsAnish Thomas, Yves Pommier, Christophe E. Redon et al.|Journal of Clinical Oncology|2017Cited by 177